What is the Return on Assets (ROA) of Algernon Pharmaceuticals this year?
The Return on Assets (ROA) of Algernon Pharmaceuticals is -1.62 undefined this year.
Algernon Pharmaceuticals ROA 2024
Algernon Pharmaceuticals ROA
-1.62
Ticker
AGN.CN
ISIN
CA01559R4008
WKN
A3DAFG
In 2024, Algernon Pharmaceuticals's return on assets (ROA) was -1.62, a 117.42% increase from the -0.74 ROA in the previous year.
Algernon Pharmaceuticals Aktienanalyse
What does Algernon Pharmaceuticals do?
Algernon Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROA Details
Understanding Algernon Pharmaceuticals's Return on Assets (ROA)
Algernon Pharmaceuticals's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.
Year-to-Year Comparison
Comparing Algernon Pharmaceuticals's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.
Impact on Investments
Investors consider Algernon Pharmaceuticals's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.
Interpreting ROA Fluctuations
Variations in Algernon Pharmaceuticals’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.
Frequently Asked Questions about Algernon Pharmaceuticals Stock
What was the ROA of Algernon Pharmaceuticals compared to the previous year?
The ROA of Algernon Pharmaceuticals has increased by 117.42% compared to the previous year.
What consequences do high ROA have for investors of Algernon Pharmaceuticals?
A high ROA is advantageous for investors of Algernon Pharmaceuticals, as it indicates that the company efficiently utilizes its assets and generates good profits.
What are the consequences of low ROA for investors in Algernon Pharmaceuticals?
A low ROA can be unfavorable for investors of Algernon Pharmaceuticals as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.
How does an increase in the ROA of Algernon Pharmaceuticals affect the company?
An increase in ROA of Algernon Pharmaceuticals can be an indicator of improved efficiency in asset utilization and higher profitability.
How does a reduction in ROA of Algernon Pharmaceuticals impact the company?
A reduction in the ROA of Algernon Pharmaceuticals can be an indicator of lower asset efficiency and profitability.
What are some factors that can influence the ROA of Algernon Pharmaceuticals?
Some factors that can influence the ROA of Algernon Pharmaceuticals include revenue, operating costs, asset structure, and industry average.
Why is the ROA of Algernon Pharmaceuticals important for investors?
The ROA of Algernon Pharmaceuticals is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.
What strategic measures can Algernon Pharmaceuticals take to improve ROA?
To improve ROA, Algernon Pharmaceuticals can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.
How much dividend does Algernon Pharmaceuticals pay?
Over the past 12 months, Algernon Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Algernon Pharmaceuticals is expected to pay a dividend of 0 CAD.
What is the dividend yield of Algernon Pharmaceuticals?
The current dividend yield of Algernon Pharmaceuticals is .
When does Algernon Pharmaceuticals pay dividends?
Algernon Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Algernon Pharmaceuticals?
Algernon Pharmaceuticals paid dividends every year for the past 0 years.
What is the dividend of Algernon Pharmaceuticals?
For the upcoming 12 months, dividends amounting to 0 CAD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Algernon Pharmaceuticals located?
Algernon Pharmaceuticals is assigned to the '-' sector.
Wann musste ich die Aktien von Algernon Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Algernon Pharmaceuticals from 6/20/2024 amounting to 0 CAD, you needed to have the stock in your portfolio before the ex-date on 6/20/2024.
When did Algernon Pharmaceuticals pay the last dividend?
The last dividend was paid out on 6/20/2024.
What was the dividend of Algernon Pharmaceuticals in the year 2023?
In the year 2023, Algernon Pharmaceuticals distributed 0 CAD as dividends.
In which currency does Algernon Pharmaceuticals pay out the dividend?
The dividends of Algernon Pharmaceuticals are distributed in CAD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Algernon Pharmaceuticals
Our stock analysis for Algernon Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Algernon Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Algernon Pharmaceuticals Revenue
- Algernon Pharmaceuticals Net Income
- Algernon Pharmaceuticals P/E
- Algernon Pharmaceuticals P/S
- Algernon Pharmaceuticals EBIT
- Algernon Pharmaceuticals Dividend
- Algernon Pharmaceuticals Stocks
- Algernon Pharmaceuticals Market capitalization
- Algernon Pharmaceuticals Debt
- Algernon Pharmaceuticals Liabilities
- Algernon Pharmaceuticals Equity
- Algernon Pharmaceuticals AAQS
- Algernon Pharmaceuticals Employees
- Algernon Pharmaceuticals ROE
- Algernon Pharmaceuticals ROA
- Algernon Pharmaceuticals ROCE